// STATE LEGISLATION TRACKER

Kansas SB 52 — Enacting the Kansas film and digital media industry production development act, providing a tax credit and sales tax exe

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: Kansas
Bill: SB 52
Filed: 2025-01-21
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Kansas SB52 appears to be a film and digital media production incentive bill, focused on tax credits and sales tax exemptions for media projects. Based on the title and listed subjects, it has no apparent connection to compounded peptides, prescribing, telehealth, clinician scope, FDA compounding rules, controlled substances, or prescription monitoring.

Key Points

No apparent change to peptide prescribing or access
No apparent impact on compounded peptide pharmacies
No apparent change to telehealth peptide care
No apparent change to NP or naturopathic scope
No apparent controlled-substance or PDMP effect

What to Watch For

Note The available bill metadata points to media production incentives, not health care or pharmacy regulation.

Note If later amendments add health, tax, or licensing language, peptide relevance should be rechecked.

Where the Bill Stands

The provided source reports that the latest OpenStates action refetch failed, so the current procedural status cannot be confirmed from the supplied metadata.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws